Yorihide Okuda

480 citations
16 papers · 391 indexed · h-index 9
Topics
Liver Disease Diagnosis and Treatment (7 papers)Fibroblast Growth Factor Research (6 papers)Liver physiology and pathology (4 papers)
Partner nations
JapanGermanyChina

In The Last Decade

Yorihide Okuda

16 papers receiving 386 citations

Peers

Yorihide Okuda
Comparison fields: 5 of 50
  • Molecular Biology 295
  • Hepatology 80
  • Cancer Research 68
  • Oncology 55
  • Surgery 43
Replace Hirokazu Uyama with:
Hirokazu Uyama Japan
Kathy Hötzel United States
Richard Ong Singapore
Chuanchao He China
Hironori Betsunoh Japan
Shunro Uchinokura Japan
Xiaonan Shi China
M Redon France
Dafna Kaufman United States
Yorihide Okuda relative to Hirokazu Uyama Japan Hirokazu Uyama's profile →
Citations per field
00.5×1.5×2.3×
Hirokazu Uyama · 1×
Citations per year

Countries citing papers authored by Yorihide Okuda

Since Specialization
Citations

This map shows the geographic impact of Yorihide Okuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yorihide Okuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yorihide Okuda more than expected).

Fields of papers citing papers by Yorihide Okuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yorihide Okuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yorihide Okuda. The network helps show where Yorihide Okuda may publish in the future.

Co-authorship network of co-authors of Yorihide Okuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yorihide Okuda. A scholar is included among the top collaborators of Yorihide Okuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yorihide Okuda. Yorihide Okuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 5
2 8
3 12
4
[A case in which good quality of life was maintained by stent therapy for duodenal stenosis caused by gallbladder cancer invasion].
1
5
[A clinical case of the esophagogastric malignancy palliated with covered metallic stent with anti-reflux mechanism].
1
6 15
7 2
8 72
9 87
10
A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
4
11
Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
4
12 76
13 43
14
Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
38
15
The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C.
6
16 17

About Yorihide Okuda

Yorihide Okuda is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 16 papers that have together received 391 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Fibroblast Growth Factor Research (6 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Hepatology (80 citations), Cancer Research (68 citations) and Molecular Biology (295 citations). Yorihide Okuda has collaborated with scholars based in Japan, Germany and China. Frequent co-authors include Hirayuki Enomoto, Hideji Nakamura, Hirokazu Uyama, Kenya Yoshida, Ichiro Kawase, Yoshihiko Kishima, Yasuhiko Tomita, Yoshihiko Hoshida, Hiroaki Ito and Morito Monden. Their work appears in journals such as Clinical Cancer Research, Annals of Surgical Oncology and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026